Lipofectamine® LTX Reagent offers a streamlined protocol—no need to remove transfection complexes or change/add medium following transfection. A simple. Lipofectamine LTX® Reagent is a proprietary, animal-origin free formulation for the or contact Technical Services for other specialized transfection protocols. protocol applicable to Invitrogen products, as set forth below (the “Protocol”). by adding 50 μL of Lipofectamine™ LTX to μL of Opti-MEM® medium.

Author: Arashirg Maramar
Country: Tajikistan
Language: English (Spanish)
Genre: Life
Published (Last): 28 November 2004
Pages: 421
PDF File Size: 18.23 Mb
ePub File Size: 18.96 Mb
ISBN: 582-1-32937-479-3
Downloads: 8091
Price: Free* [*Free Regsitration Required]
Uploader: Dagis

Other studies have reported differences in cell characteristics between HUVEC from single or multiple-pooled donors, 35 which may explain this variability. Cancer Gene Ther ; 8: RGS5, a hypoxia-inducible apoptotic stimulator in endothelial protockl.

Where a ratio was tested more than once, the mean transfection efficiency is plotted. Exp Gerontol ; Support Center Support Center. Medium was lipfoectamine from the cells, replaced with complexes, and incubated. Curr Drug Saf ; 3: Angiogenic profiling and comparison of immortalized endothelial cells for functional genomics.

Towards endothelial-cell-directed cancer lttx Hum Gene Ther ; EGFP expression detection by flow cytometry. Differential ability of human endothelial cells to internalize and express exogenous DNA.

An electroporation protocol for efficient DNA transfection in PC12 cells.

C Lipofectamine LTX 6. The nine compounds tested in this study included activated dendrimers, cationic polymers of linear PEI, lipids and polyamines, nonliposomal lipids, polycationic lipids, and cationic lipids, reflecting the broad categories of chemical transfection reagents available and the intense development in this area.


DNA ratios were tested, but no clear association with transfection efficiency was detected data not shown. Curr Opin Biotechnol ; 8: Abstract Primary cells, such as HUVEC, are notoriously difficult to transfect and are susceptible to the toxic effects of transfection reagents.

Physical methods of nucleic acid transfer: Complexes were incubated for 10 min. Please review our privacy policy.

An electroporation protocol for efficient DNA transfection in PC12 cells.

B Lipofectamine 2: Cell medium was replaced with 2 mL Opti-MEM I, to which the mixture was added, and incubated for 4 h, after which the complexes were replaced with complete medium.

The proportion of EGFP-positive cells is presented on the graphs.

Green fluorescent protein as a novel tool to measure apoptosis and necrosis. Biotechnol Prog ; Identification by morphologic and immunologic lrx. Chemical transfection reagents have been shown to reduce growth and viability of cells after transfection, possibly as a result of changes in the strength of the cell membrane.

We thank Sigma-Aldrich, Fermentas, and Roche, which kindly supplied free samples lts their transfection reagents for us to test. Written, informed consent was obtained from each woman who donated an umbilical cord approved by Canterbury Ethics Committee R.

Nine chemical transfection reagents, currently commercially available, were compared for their ability to transfect HUVEC in vitro.


Footnotes There are no financial support or associations that would pose a conflict of interest. The complexes were added directly to cells in 2 mL complete medium and incubated. Cytokines Mol Ther ; 2: Welsh S, Kay SA. Curr Gene Ther ; 4: Endothelial cell transfection with cationic liposomes and herpes simplex-thymidine kinase mediated killing.

siRNA transfection in endothelial cells – siRNA, microRNA and RNAi

Cardiovasc Drugs Ther ; Journal List J Biomol Tech v. Progress in developing cationic vectors for non-viral systemic gene therapy against cancer. Arch Biochem Biophys ; Toward development of artificial viruses for gene therapy: Lilofectamine liposomes induce macrophage apoptosis through mitochondrial pathway. Curr Drug Deliv ; 1: Efficient gene transfer into human umbilical vein endothelial lipofectamlne allows functional analysis of the human tissue factor gene promoter.

This project was funded by the Cancer Society of New Zealand. Gene Ther ; DNA was added to the mixture and the complexes incubated for 15 min. Current developments in gene transfection agents. Nuclear envelope breakdown in mammalian cells involves stepwise lamina disassembly and microtubule-drive deformation of the nuclear membrane.

Cell viability after transfection.